GB0221694D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0221694D0
GB0221694D0 GBGB0221694.3A GB0221694A GB0221694D0 GB 0221694 D0 GB0221694 D0 GB 0221694D0 GB 0221694 A GB0221694 A GB 0221694A GB 0221694 D0 GB0221694 D0 GB 0221694D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0221694.3A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0221694.3A priority Critical patent/GB0221694D0/en
Publication of GB0221694D0 publication Critical patent/GB0221694D0/en
Priority to ARP030103352A priority patent/AR041269A1/es
Priority to PCT/EP2003/010350 priority patent/WO2004026890A1/fr
Priority to TW092125414A priority patent/TW200413402A/zh
Priority to AU2003260509A priority patent/AU2003260509A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/167—Purine radicals with ribosyl as the saccharide radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Vascular Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0221694.3A 2002-09-18 2002-09-18 Compounds Ceased GB0221694D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB0221694.3A GB0221694D0 (en) 2002-09-18 2002-09-18 Compounds
ARP030103352A AR041269A1 (es) 2002-09-18 2003-09-16 Compuesto de adenosina, composicion farmaceutica que lo comprende y su uso para la fabricacion de un medicamento
PCT/EP2003/010350 WO2004026890A1 (fr) 2002-09-18 2003-09-16 Composes acetyleniques
TW092125414A TW200413402A (en) 2002-09-18 2003-09-16 Acetylene compounds
AU2003260509A AU2003260509A1 (en) 2002-09-18 2003-09-16 Acetylene compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0221694.3A GB0221694D0 (en) 2002-09-18 2002-09-18 Compounds

Publications (1)

Publication Number Publication Date
GB0221694D0 true GB0221694D0 (en) 2002-10-30

Family

ID=9944337

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0221694.3A Ceased GB0221694D0 (en) 2002-09-18 2002-09-18 Compounds

Country Status (5)

Country Link
AR (1) AR041269A1 (fr)
AU (1) AU2003260509A1 (fr)
GB (1) GB0221694D0 (fr)
TW (1) TW200413402A (fr)
WO (1) WO2004026890A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5594722B2 (ja) * 2010-01-28 2014-09-24 国立大学法人東北大学 Ｒｎａ型非天然ヌクレオシド誘導体を調製するための中間体化合物の製造方法
CN103209987B (zh) 2010-09-22 2017-06-06 艾丽奥斯生物制药有限公司 取代的核苷酸类似物
AU2012358804B2 (en) 2011-12-22 2018-04-19 Alios Biopharma, Inc. Substituted phosphorothioate nucleotide analogs
WO2013142124A1 (fr) 2012-03-21 2013-09-26 Vertex Pharmaceuticals Incorporated Formes solides d'un promédicament nucléotidique thiophosphoramidate
US9012427B2 (en) 2012-03-22 2015-04-21 Alios Biopharma, Inc. Pharmaceutical combinations comprising a thionucleotide analog

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9723590D0 (en) * 1997-11-08 1998-01-07 Glaxo Group Ltd Chemical compounds
US20040162422A1 (en) * 2001-03-20 2004-08-19 Adrian Hall Chemical compounds

Also Published As

Publication number Publication date
AU2003260509A1 (en) 2004-04-08
WO2004026890A1 (fr) 2004-04-01
AR041269A1 (es) 2005-05-11
TW200413402A (en) 2004-08-01

Similar Documents

Publication Publication Date Title
GB0212785D0 (en) Compounds
EP1558585A4 (fr) Composes neurologiquement actifs
GB0209022D0 (en) Compounds
GB0200283D0 (en) Compounds
GB0210762D0 (en) Compounds
GB0211418D0 (en) Compounds
GB0207323D0 (en) Compounds
GB0212399D0 (en) Compounds
GB0203778D0 (en) Compounds
GB0221694D0 (en) Compounds
GB0213011D0 (en) Compounds
GB0213122D0 (en) Compounds
GB0209244D0 (en) Compounds
AU2003275480A8 (en) Compounds
GB0203811D0 (en) Compounds
GB0206981D0 (en) Compounds
GB0207270D0 (en) Compounds
GB0203438D0 (en) Compounds
GB0204721D0 (en) Compounds
GB0204784D0 (en) Compounds
GB0206892D0 (en) Compounds
GB0206924D0 (en) Compounds
GB0203900D0 (en) Compounds
GB0203812D0 (en) Compounds
GB0203807D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)